|
Beta Drugs Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
1658.43 Cr.
|
P/BV
|
9.17
|
Book Value (Rs.)
|
179.17
|
|
52 Week High/Low (Rs.)
|
2170/1429
|
FV/ML
|
10/1
|
P/E(X)
|
39.10
|
|
Bookclosure
|
26/03/2025
|
EPS (Rs.)
|
42.02
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 42.02 | 37.90 | 31.95 | 25.82 | 12.20 |
| Diluted EPS (Rs.) | 42.02 | 37.90 | 31.95 | 25.82 | 12.20 |
| Cash EPS (Rs.) | 54.42 | 48.08 | 42.78 | 33.37 | 19.34 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 195.25 | 163.43 | 127.82 | 96.05 | 71.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 195.25 | 163.43 | 127.82 | 96.05 | 71.37 |
| Revenue From Operations / Share (Rs.) | 358.96 | 307.59 | 236.24 | 191.22 | 120.79 |
| PBDIT / Share (Rs.) | 80.28 | 63.82 | 56.05 | 45.20 | 26.26 |
| PBIT / Share (Rs.) | 67.89 | 53.65 | 45.22 | 37.65 | 19.11 |
| PBT / Share (Rs.) | 56.44 | 50.71 | 42.70 | 35.68 | 16.59 |
| Net Profit / Share (Rs.) | 42.02 | 37.90 | 31.95 | 25.82 | 12.20 |
| NP After MI And SOA / Share (Rs.) | 42.02 | 37.90 | 31.95 | 25.82 | 12.20 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 22.36 | 20.74 | 23.72 | 23.63 | 21.73 |
| PBIT Margin (%) | 18.91 | 17.44 | 19.14 | 19.69 | 15.81 |
| PBT Margin (%) | 15.72 | 16.48 | 18.07 | 18.65 | 13.73 |
| Net Profit Margin (%) | 11.70 | 12.32 | 13.52 | 13.50 | 10.09 |
| NP After MI And SOA Margin (%) | 11.70 | 12.32 | 13.52 | 13.50 | 10.09 |
| Return on Networth / Equity (%) | 21.52 | 23.19 | 24.99 | 26.88 | 17.08 |
| Return on Capital Employeed (%) | 20.54 | 30.43 | 32.10 | 33.24 | 22.09 |
| Return On Assets (%) | 9.72 | 14.33 | 15.48 | 15.72 | 9.97 |
| Long Term Debt / Equity (X) | 0.64 | 0.03 | 0.05 | 0.12 | 0.16 |
| Total Debt / Equity (X) | 0.67 | 0.06 | 0.13 | 0.17 | 0.21 |
| Asset Turnover Ratio (%) | 1.05 | 1.31 | 1.27 | 1.09 | 0.82 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 3.22 | 2.10 | 2.03 | 1.98 | 1.99 |
| Quick Ratio (X) | 2.64 | 1.51 | 1.54 | 1.52 | 1.53 |
| Inventory Turnover Ratio (X) | 6.61 | 4.17 | 4.16 | 5.70 | 4.47 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 11.60 | 21.76 | 22.31 | 22.88 | 10.43 |
| Interest Coverage Ratio (Post Tax) (%) | 7.72 | 13.92 | 13.72 | 14.07 | 5.85 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1909.20 | 1168.47 | 599.62 | 542.92 | 119.61 |
| EV / Net Operating Revenue (X) | 5.27 | 3.95 | 2.64 | 2.95 | 1.03 |
| EV / EBITDA (X) | 23.56 | 19.04 | 11.13 | 12.49 | 4.74 |
| MarketCap / Net Operating Revenue (X) | 5.31 | 4.01 | 2.65 | 2.96 | 0.99 |
| Price / BV (X) | 9.76 | 7.55 | 4.90 | 5.89 | 1.68 |
| Price / Net Operating Revenue (X) | 5.31 | 4.01 | 2.65 | 2.96 | 0.99 |
| EarningsYield | 0.02 | 0.03 | 0.05 | 0.04 | 0.10 |
